Clinical Trial Update: Comparison of a Prophylactic Intraligamentary Injection of Piroxicam Versus Mepecaine of Post-endodontic Pain [NA]

View source ↗

Summary

A clinical trial compares prophylactic intraligamentary injection of piroxicam to mepecaine for post-endodontic pain in irreversible pulpitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Mepecaine (mepecaine)
• Piroxicam (piroxicam)

Snippet

Sponsor: Cairo University | Conditions: Pulpitis - Irreversible | NA | Status: UNKNOWN